Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 1

Conditions

Vomiting 3Pain 3Nausea 3Neoplasms 2Taste Disorders 1Parasomnias 1Pancreatic Neoplasms 1Olfaction Disorders 1Cancer Pain 1Breast Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1

Interventions

Dexamethasone 22Ondansetron 20Aprepitant 20Palonosetron 17Granisetron 11Calcium Dobesilate 8Therapeutics 7Olanzapine 6dexamethasone acetate 5Doxorubicin 5Cyclophosphamide 5casopitant 4Acupressure 4netupitant 3dolasetron 3Yoga 3Vincristine 3Radiotherapy 3Dronabinol 3Analgesia 3ginger extract 2fosaprepitant 2dexamethasone 21-phosphate 2Tropisetron 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Prochlorperazine 2Metoclopramide 2Mesna 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Nausea × Dronabinol × Clear all
NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed
91 enrolled

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT00553059 2020-10-09

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

M.D. Anderson Cancer Center

Phase 3 Completed
62 enrolled 15 charts

Nausea, Vomiting

NCT00314808 2014-07-16

A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas

Duke University

Phase 1 Completed
33 enrolled 9 charts
CNS

Brain Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡